WebbZurück zum Zitat Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowitz SD, Nessel CC, Fox KA, Califf RM, Piccini JP, Patel MR, ROCKET AF Steering Committee and Investigators (2015) Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the … Webb17 feb. 2024 · Hyperkalemia, hyponatremia: Decreased digoxin distribution to heart and muscle Hypokalemia: Increased digoxin distribution to heart and muscles Concomitant quinidine therapy: Decreased V d Chronic renal failure: 4 to 6 L/kg Decreased sodium/potassium ATPase activity - decreased tissue binding Neonates, full-term: 7.5 to …
Vorhofflimmern Kommentar zu den 2016 Leitlinien der …
Webb20 jan. 2024 · General. Digoxin is an old drug, perhaps ancient by some standards. It is a purified cardiac glycoside extracted from the purple foxglove (digitalis purpurea) plant. Trade names for digoxin include Lanoxin, Digitek, and Lanoxicaps. It is also a generic medication. Digoxin has been used in patients with atrial fibrillation and congestive heart … Webb12 juni 2024 · If the level is too high, toxicity may occur. Digoxin dosage may be adjusted based on levels measured. Therapeutic digoxin level: 0.5 to 2.0 nanograms/mL (1.02 to 2.56 nanomol/L). But the right level for some people may vary depending on the situation. Toxic digoxin level: greater than 2.4 nanograms/mL (3.07 nmol/L) black a2 paper
Fetal cardiac arrhythmias: Current evidence : Annals of Pediatric ...
Webb11 apr. 2024 · Some meta-analyses, which primarily included observational data, have suggested a potentially higher risk of harm in HF patients with AF receiving digoxin, whereas another meta-analysis of non-RCT data found no adverse effects on mortality. 37–39 Given the lack of clear evidence and the narrow therapeutic window of digoxin, … Webb13 mars 2024 · Serum digoxin concentration is usually greater than the therapeutic range of 0.6 to 1.2 nanomol/L (0.5 to 0.9 nanograms/mL). In addition to pharmaceuticals, toxicity can also occur from exposure to a number of plants and animals that contain cardioactive corticosteroids, including dogbane, foxglove, lily of the valley, oleander, yellow oleander, … Webb14 apr. 2024 · Currently, there are no clinical studies available to evaluate FMT outcome in HF patients, but FMT has great therapeutic potential and represents a promising direction for future research [101,182]. According to ClinicalTrials.gov there are four clinical trials focused on the efficacy and safety of different strategies regarding gut microbiota … black a2